Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03405155
Title Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

skin melanoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.